299 related articles for article (PubMed ID: 34348969)
1. Increased Serum Neurofilament Light and Thin Ganglion Cell-Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis.
Lin TY; Vitkova V; Asseyer S; Martorell Serra I; Motamedi S; Chien C; Ditzhaus M; Papadopoulou A; Benkert P; Kuhle J; Bellmann-Strobl J; Ruprecht K; Paul F; Brandt AU; Zimmermann HG
Neurol Neuroimmunol Neuroinflamm; 2021 Sep; 8(5):. PubMed ID: 34348969
[TBL] [Abstract][Full Text] [Related]
2. Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome.
Zimmermann HG; Knier B; Oberwahrenbrock T; Behrens J; Pfuhl C; Aly L; Kaminski M; Hoshi MM; Specovius S; Giess RM; Scheel M; Mühlau M; Bellmann-Strobl J; Ruprecht K; Hemmer B; Korn T; Paul F; Brandt AU
JAMA Neurol; 2018 Sep; 75(9):1071-1079. PubMed ID: 29710121
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
[TBL] [Abstract][Full Text] [Related]
4. Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study.
Tavazzi E; Jakimovski D; Kuhle J; Hagemeier J; Ozel O; Ramanathan M; Barro C; Bergsland N; Tomic D; Kropshofer H; Leppert D; Michalak Z; Lincoff N; Dwyer MG; Benedict RHB; Weinstock-Guttman B; Zivadinov R
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32424064
[TBL] [Abstract][Full Text] [Related]
5. Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.
Wauschkuhn J; Solorza Buenrostro G; Aly L; Asseyer S; Wicklein R; Hartberger JM; Ruprecht K; Mühlau M; Schmitz-Hübsch T; Chien C; Berthele A; Brandt AU; Korn T; Paul F; Hemmer B; Zimmermann HG; Knier B
Eur J Neurol; 2023 Apr; 30(4):982-990. PubMed ID: 36635219
[TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis.
Bsteh G; Berek K; Hegen H; Teuchner B; Buchmann A; Voortman MM; Auer M; Wurth S; Zinganell A; Di Pauli F; Deisenhammer F; Khalil M; Berger T
Mult Scler; 2020 Nov; 26(13):1682-1690. PubMed ID: 31668116
[TBL] [Abstract][Full Text] [Related]
7. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
[TBL] [Abstract][Full Text] [Related]
8. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
[TBL] [Abstract][Full Text] [Related]
10. Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.
Reinert MC; Benkert P; Wuerfel J; Michalak Z; Ruberte E; Barro C; Huppke P; Stark W; Kropshofer H; Tomic D; Leppert D; Kuhle J; Brück W; Gärtner J
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32404429
[TBL] [Abstract][Full Text] [Related]
11. Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort.
Steffen F; Uphaus T; Ripfel N; Fleischer V; Schraad M; Gonzalez-Escamilla G; Engel S; Groppa S; Zipp F; Bittner S
Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36411080
[TBL] [Abstract][Full Text] [Related]
12. NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study.
Uphaus T; Steffen F; Muthuraman M; Ripfel N; Fleischer V; Groppa S; Ruck T; Meuth SG; Pul R; Kleinschnitz C; Ellwardt E; Loos J; Engel S; Zipp F; Bittner S
EBioMedicine; 2021 Oct; 72():103590. PubMed ID: 34571362
[TBL] [Abstract][Full Text] [Related]
13. Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
Fox RJ; Cree BAC; de Sèze J; Gold R; Hartung HP; Jeffery D; Kappos L; Montalban X; Weinstock-Guttman B; Singh CM; Altincatal A; Belviso N; Avila RL; Ho PR; Su R; Engle R; Sangurdekar D; de Moor C; Fisher E; Kieseier BC; Rudick RA
Neurology; 2024 May; 102(9):e209357. PubMed ID: 38648580
[TBL] [Abstract][Full Text] [Related]
14. Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment.
Højsgaard Chow H; Petersen ER; Olsson A; Hejgaard Laursen J; Bredahl Hansen M; Oturai AB; Soelberg Sørensen P; Bach Søndergaard H; Sellebjerg F
Mult Scler Relat Disord; 2024 Jun; 88():105701. PubMed ID: 38889559
[TBL] [Abstract][Full Text] [Related]
15. MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple Sclerosis.
Rosso M; Healy BC; Saxena S; Paul A; Bjornevik K; Kuhle J; Benkert P; Leppert D; Guttmann C; Bakshi R; Weiner HL; Chitnis T
J Neuroimaging; 2021 Mar; 31(2):388-393. PubMed ID: 33476489
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.
Bittner S; Steffen F; Uphaus T; Muthuraman M; Fleischer V; Salmen A; Luessi F; Berthele A; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Linker R; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kuempfel T; Weber F; Zettl UK; Ziemann U; Tumani H; Groppa S; Mühlau M; Lukas C; Hemmer B; Wiendl H; Gold R; Zipp F;
EBioMedicine; 2020 Jun; 56():102807. PubMed ID: 32460167
[TBL] [Abstract][Full Text] [Related]
17. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.
Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W
J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578
[TBL] [Abstract][Full Text] [Related]
18. Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.
Uher T; Havrdova EK; Benkert P; Bergsland N; Krasensky J; Srpova B; Dwyer M; Tyblova M; Meier S; Vaneckova M; Horakova D; Zivadinov R; Leppert D; Kalincik T; Kuhle J
Mult Scler; 2021 Nov; 27(13):2001-2013. PubMed ID: 34612753
[TBL] [Abstract][Full Text] [Related]
19. Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
Maggi P; Kuhle J; Schädelin S; van der Meer F; Weigel M; Galbusera R; Mathias A; Lu PJ; Rahmanzadeh R; Benkert P; La Rosa F; Bach Cuadra M; Sati P; Théaudin M; Pot C; van Pesch V; Leppert D; Stadelmann C; Kappos L; Du Pasquier R; Reich DS; Absinta M; Granziera C
Neurology; 2021 Aug; 97(6):e543-e553. PubMed ID: 34088875
[TBL] [Abstract][Full Text] [Related]
20. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Ratchford JN; Saidha S; Sotirchos ES; Oh JA; Seigo MA; Eckstein C; Durbin MK; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome SD; Balcer LJ; Frohman EM; Calabresi PA
Neurology; 2013 Jan; 80(1):47-54. PubMed ID: 23267030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
